mTOR Regulates the Phenotypic Modulation of De-differentiated Mesenchymal Stem Cells in Vascular Disease
ISEF · 2016 Translational Medical Science Fourth Award
Overview
Atherosclerosis, a form of cardiovascular disease, accounts for 17.3 million deaths/year(Mozaffarian,2014). Characterized by plaque formation in arteries, it leads to myocardial infarctions and strokes. The dysregulated growth/motility of smooth muscle cells(SMCs) is a key step in pathogenesis. However, mechanisms involved in SMC dysfunction are unknown. To address this gap, this study postulated de-differentiation potentials of SMCs to mesenchymal stem cells(SMC-MSC). Immunofluorescence studies were used to identify this potential; a positive staining for MSC markers and a decreased staining for SMC markers were observed, indicating dedifferentiation. SMC de-differentiation has not been previously shown with unequivocal support nor has it been linked to atherosclerosis, making this a novel finding. It was also proposed that the mTOR pathway mediates these SMC-MSCs. This cell-cycle regulating pathway is linked to atherosclerosis, as its inhibitor, rapamycin, is used in angioplasty to halt cell infiltration; however, mechanisms by which rapamycin functions are unknown. Rapamycin treated SMC-MSCs underwent immediate morphological changes, approaching senescence, indicating its possible mechanism of function. However, after mTOR inhibition in non-dedifferentiated MSCs, cell count increased. These results demonstrate mTOR’s mediation of SMC-MSCs and its little effect on adult MSCs. These findings suggest an increased use of mTOR inhibitors in treatment, as they downregulate proliferation of plaque causing cells and protect inflammation reducing MSCs. This study also indicates that the anti-atherogenic target is SMC-MSCs, not only SMCs, thus providing a better understanding of atherosclerotic to enable specific, targeted treatment, which will in the long run, lead to a cure.
Awards (1)
- Fourth Award of $500 $500
Competition history
- ISEF 2016
Resources
Related projects
ISEF · 2026
TGF-ß3–Driven Reversal of Mesenchymal Stem Cell Senescence for Improved Regenerative Medicine Applications
ISEF · 2015
Contact Dependency of Immune Cells and Endothelial Cells in Promoting Angiogenesis
ISEF · 2025
Investigating the Synergistic Role of IL-1BETA and TGF-BETA in Endothelial-to- Mesenchymal Transition in Coronary Artery Disease
ISEF · 2018
Role of Telomerase in Vascular Function and Exploration of Mitochondrial Dynamics: A Novel Approach to Treatment of Vascular Dysfunction
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair